Additive Solutions for the Suspension of Blood Products Framework Agreement

Descriptions

Establishment of a Framework Agreement with the following Blood Establishments as
beneficiaries - NHS Blood and Transplant; the Welsh Blood Service (WBS); the Northern
Ireland Blood Transfusion Service (NIBTS); the Scottish National Blood Transfusion Service
(SNBTS); the Australian Red Cross Lifeblood (ARCL), the New Zealand Blood Service
(NZBS) and the Irish Blood Transfusion Service (IBTS).
Additive Solutions for the Suspension of Blood Products:
Lot 1: Additive solution for the suspension of pooled platelets, granulocytes and other
components derived from whole blood; Additive solution for the suspension of single donor
apheresis derived platelets;
Lot 2: SAGM solution for the routine washing and re-suspension of red cells
during the production of specialist blood components in accordance with the Guidelines for
the Blood Transfusion Services in the UK details of which can be found at the following
website https://www.transfusionguidelines.org/red-book